Inactivation of foot-and-mouth virus by methyl glyoxal
Inactivation of foot-and-mouth virus by methyl glyoxal
Amfiteatrov, F. Z.
Access the full text:
NOT AVAILABLE
Inactivation of foot-and-mouth virus by methyl glyoxal
Amfiteatrov, F. Z.
2013/US/US2013_60.rdf
In AGRIS since
Congratulations
Publications saved
Procurement
Governing Bodies
Country Offices
Follow us on
Download our AppMethod for reducing toxic effects of methyl-glyoxal bis-guanylhydrazone - Patent - Europe PMC
Europe PMC requires Javascript to function effectively.
Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please
turn on Javascript support in your web browser and reload this page.
https://orcid.org
Search worldwide, life-sciences literature
Method for reducing toxic effects of methyl-glyoxal bis-guanylhydrazone
(PAT - US4520031)
KNIGHT III WILLIAM A
Patent: 
United STATES Patent - United States
Application:
Publication:
A method of treating cancers or advanced malignant disease involving the weekly administration of methyl-glyoxal bis-guanylhydrazone in amounts of 250-1,000 mg/m2 per week. In particular the administration involves a weekly dosing regimen and dose escalation over the series of treatments from an initial dosage which may be 250 mg/m2.
Priority number:
Classifier:}